PROGRAM REMEDY seminar 2025

Her finner du programmet for seminaret 5. og 6. mars.
Wednesday March 5th
0930 |
Arrival, coffee |
1000 |
Welcome Ida K. Bos-Haugen, Vice Director of REMEDY |
1010 |
Status update and presentation of the 2024 annual report Espen A. Haavardsholm, Professor in Rheumatology and Director of REMEDY |
1025 |
The impact of REMEDY through the eyes of a hospital director Kari-Jussie Lønning, CEO Diakonhjemmet Hospital |
1040 |
State-of-the-art: The use of qualitative and mixed methods designs in RMD studies Emma Dures, Professor in Rheumatology and Psychology, UWE Bristol, UK |
1110 |
State-of-the-art: Challenging our view on chronic pain Camilla Svensson, Professor, Karolinska Institute, Sweden |
1140 |
Coffee break |
1200 |
State-of-the-art: Axial spondyloarthritis: Development of a field Désirée van der Heijde, Professor in Rheumatology, Leiden University Medical Center, the Netherlands |
1230 |
State-of-the-art: The promise of CAR-T for patients with rheumatic diseases Christina Bergmann, Rheumatologist, University of Erlangen, Germany |
1300 |
Lunch / "Networking while in activity" - Choice of cross-country skiing or cultural sightseeing-Glasslåven / Check-in |
1545 |
Thematic workshops (4 parallel sessions) |
1645 |
Coffee break |
1700 |
Presentations from the Young Researcher Program grant recipients Lena Bugge Nordberg, Abel Tesfaye og Øyvind Bakke |
1730 |
"Hjelp, jeg må formidle!" Hvordan få noe komplisert til å bli forståelig for utenforstående? Helene Uri, PhD, linguist and author |
1830 |
End of program |
1930 |
Dinner |
Thursday March 6th
0900 |
From evolution to epidemic: Understanding osteoarthritis as a mismatch disease Ian Wallace, Anthropologist and Assistant Professor, The University of New Mexico, USA.
|
0945 |
An update of REMEDY activities Introduction from Ida K. Bos-Haugen, and poster session with work package leaders and co-leaders |
1020 |
Poster session, coffee break and mingling |
1040 |
Project discussions Program will be based on projects submitted during registration |
1140 |
Project discussions Program will be based on projects submitted during registration |
1240 |
Lunch |
1340 |
What is the value of real world data compared to RCTs in future? Robert Landewé, Professor in Rheumatology, Amsterdam University Medical Center, the Netherlands |
1410 |
Debatt. Komorbiditet ved revmatisk sykdom: Behandle med medisiner eller livsstilsintervensjoner? Eirik Ikdahl, Postdoctoral researcher in REMEDY, co-leader of work package 4, and rheumatology fellow at Oslo University Hospital Ole Petter Hjelle. Associate Professor, Inland Norway University of Applied Scieces. Aka “Treningslegen”. |
1455 |
Farewell |
1500 |
End of program |